Chemotherapy-induced fatal hepatitis B virus reactivation in a small-cell lung cancer patient

Hepatitis B virus (HBV) reactivation during chemotherapy is a major concern and is widely reported, particularly in association with hematological malignancies and lymphomas. While lung cancer ranks first in incidence and mortality worldwide, HBV reactivation has been largely overlooked in this dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Lei, Wang, Fang, Zou, Bing-Wen, Ding, Zhen-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038378/
https://www.ncbi.nlm.nih.gov/pubmed/27699030
http://dx.doi.org/10.3892/mco.2016.989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038378/
https://www.ncbi.nlm.nih.gov/pubmed/27699030
http://dx.doi.org/10.3892/mco.2016.989

Ejemplares similares